Effect of Abdominal Wall Injections on Abdominal Pain

Recruiting now · Phase 4

Conditions studied: Anterior Cutaneous Nerve Entrapment Syndrome

In brief

This is a prospective cohort study of outpatient adults with chronic abdominal wall pain receiving abdominal wall injections, as part of their usual care, with lidocaine. Subjects will be recruited at the outpatient gastroenterology clinic at OHSU.

Key facts

Study ID

NCT06121466

Run by

Oregon Health and Science University

People needed

45

Starts

2023-01-01

Expected to finish

2025-12-01

Last updated by the study team

2025-09-02

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Localized abdominal wall pain
• Average daily pain (7-day recall) ≥ 3 on a scale of 0-10
• Suspected abdominal wall etiology for abdominal pain
• Positive Carnett's sign or pain near an incisional site
• 18 years of age or older

You may not qualify if…

• Suspected visceral etiology for the abdominal pain
• Severe allergy to lidocaine
• Unwillingness or inability to provide informed consent
• Low probability of follow-up
• Abdominal wall hernia noted at the point of pain
• History of trigger point injections for abdominal pain
• Bleeding disorder
• Pregnancy, incarceration or decisionally impaired

Where it is running

• OHSU — Portland, Oregon, United States (enrolling)
• Oregon Health Sciences University — Portland, Oregon, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.